VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 12, 2008) - Allon Therapeutics Inc. (TSX:NPC) reported today in its Second Quarter 2008 operating results that the Company achieved all its clinical and financial objectives during the quarter and is on track to achieve all its 2008 milestones, including a partnership with a large pharmaceutical company.
